Mikhaila Richards September 19, 2022 Person Mikhaila Richards joined KFF in 2022 as a communications officer. She previously worked at the Association for American Medical Colleges, the National Association of County and City Health Officials, Blue State Digital, and the Advisory Board Company. Richards earned a bachelor’s degree in government from Smith College and a master’s…
Premiums and Worker Contributions Among Workers Covered by Employer-Sponsored Coverage, 1999-2024 October 9, 2024 Interactive This graphing tool allows users to explore trends in workplace-sponsored health insurance premiums and worker contributions over time for different categories of employers based on results from the annual Employer Health Benefits Survey. Breakouts are available by firm size, region and industry, as well as for firms with relatively few or many part-time workers, higher- or lower-wage workers, and older or younger workers.
Oona Zenda December 7, 2022 Person Oona Zenda, Digital Producer and Illustrator, works on KFF Health News’s websites and its social media team. Based in New York City, she built the visual vocabulary for the “American Diagnosis” and “Epidemic” podcasts. Before pivoting to apply her artist’s sensibility to public health journalism, she trained as a sushi…
Lynne Shallcross December 9, 2022 Person Lynne Shallcross, senior digital editor, joined KFF Health News after earning a master’s in journalism from the University of California-Berkeley, where she was a Kaiser Permanente Health Policy Journalism Fellow. Her interactive project on health apps won a 2015 award from the Online News Association.
State Medicaid Program Coverage of Tobacco Dependence Treatments by Type of Coverage February 10, 2025 State Indicator
Medicare Part D Enrollees Without Low-Income Subsidies (LIS) With Drug Spending Above the Catastrophic Threshold January 19, 2024 State Indicator
KFF Prescription Drug Advertisements Poll: January 2025 February 11, 2025 Poll Finding KFF’s January 2025 Prescription Drug Advertisements Poll looks at the public’s experiences with prescription drug advertisements, whether they’ve talked to a doctor about advertised drugs, and how this has influenced the care they receive.